Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation

We evaluated anti-spike protein antibody (anti-S) production in 130 hematopoietic stem cell transplant (HSCT) recipients who received the coronavirus disease-2019 vaccine. Sixty-five received allo-HSCT and 65 received auto-HSCT. Disease-specific treatments were being administered to 43.1% of allo-HS...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsushima, Takafumi, Terao, Toshiki, Narita, Kentaro, Fukumoto, Ami, Ikeda, Daisuke, Kamura, Yuya, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011370/
https://www.ncbi.nlm.nih.gov/pubmed/35426579
http://dx.doi.org/10.1007/s12185-022-03325-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011370/
https://www.ncbi.nlm.nih.gov/pubmed/35426579
http://dx.doi.org/10.1007/s12185-022-03325-9

Ejemplares similares